The Post-Pandemic Evolution of Antiviral Research
December 22, 2025
The pandemic catalyzed a transformation in antiviral R&D. From better data to open collaboration, Tetiana Matviyuk of Enamine describes how the landscape has evolved.
3 min read
False
Advertisement
December
New Approach Methodologies: Why the Future of Drug Development Must Be Human
December 18, 2025
NAMs aren’t just a scientific upgrade, but a moral and practical necessity. The tools are ready. The question is: does the industry have the will to use them?
3 min read
Promising Data For Off-the-Shelf Gene-edited Cell Therapy
December 17, 2025
New clinical results outline patient responses to a donor-derived, gene-edited cell therapy in relapsed and refractory T-cell leukemia
2 min read
Bridging the Digital Divide: How Collaboration and Standardization Are Shaping the Future of Biotech
December 17, 2025
The promise of cell and gene therapy is boundless, but data silos are holding it back. Standardization, interoperability, and collaboration can move data as freely as science itself.
5 min read
This Week’s Biopharma News: New Pharma Legislation in Europe
December 16, 2025
Our latest news roundup reports on the oversubscribed financing for Cellular Origins, FDA approval for Amgen, CAR-T cell therapy outcomes, and more
5 min read
How Mixing FSP and FSO Models Bring Agility to Modern Clinical Development
December 15, 2025
Clinical trials are becoming longer, costlier and more complex, but a growing number of sponsors are finding agility in a hybrid approach.
4 min read
Scratching the Surface of Microneedle Array Patches
December 12, 2025
Why the industry should open its eyes to the benefits of microneedle array patches for drug delivery.
5 min read
Outsmarting Cancer: The “Trojan Horse” of Gene Therapy
December 11, 2025
Borrowing strategy from ancient Greece, Trogenix hides its therapeutic warriors inside tumor cells. CEO Ken Macnamara discusses how.
5 min read
Rebuilding Confidence in UK Pharma Manufacturing
December 11, 2025
The UK’s pharma manufacturing base still has potential, but only if companies modernize operations, boost efficiency, and show global investors that the UK can compete on cost and capability.
6 min read
This Week’s CGT News: Vertex’s Gene Therapies Show Promise in Younger Children
December 10, 2025
Our latest news roundup reports on new data for Vertex’s exa-cel, funding for a cell therapy for breast cancer, and new technologies for manufacturing
3 min read
Browse by Topics
Interviews
Cell & Gene
Bioprocessing
Drug Delivery
Drug Discovery
Development & Clinical
Formulation
Facilities & Equipment
Outsourcing
Packaging
Regulation & Standards
Small Molecules
Supply Chain
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blogs